182 related articles for article (PubMed ID: 15475752)
21. Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease.
Velayos FS; Sandborn WJ
Inflamm Bowel Dis; 2004 Sep; 10(5):657-60. PubMed ID: 15472531
[TBL] [Abstract][Full Text] [Related]
22. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy.
Redmond M; Quinn J; Murphy P; Patchett S; Leader M
J Clin Pathol; 2007 Jan; 60(1):80-1. PubMed ID: 17213349
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary Infection Due to Reactivation of Latent Epstein-Barr Virus in a Patient With Crohn's Disease Treated With Infliximab.
Zhang Y; Tian F; Li H
Inflamm Bowel Dis; 2022 Jun; 28(6):e80-e81. PubMed ID: 35657372
[No Abstract] [Full Text] [Related]
24. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
Chen SC; Cummings OW; Hartley MP; Filomena CA; Cho WK
Dig Dis Sci; 2006 May; 51(5):952-5. PubMed ID: 16670938
[TBL] [Abstract][Full Text] [Related]
25. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
Francolla KA; Altman A; Sylvester FA
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):193-5. PubMed ID: 18664872
[No Abstract] [Full Text] [Related]
26. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
[No Abstract] [Full Text] [Related]
27. EBV hepatitis in a young Crohn's disease patient on prolonged remission with azathioprine.
Angelucci E; Cesarini M; Caturelli E; Vernia P
Inflamm Bowel Dis; 2011 Feb; 17(2):E1. PubMed ID: 20848464
[No Abstract] [Full Text] [Related]
28. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
Börcek P; Özdemir BH; Özgün G; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
[TBL] [Abstract][Full Text] [Related]
29. [Epstein-Barr virus-associated large B-cell lymphoma in a patient with colitis ulcerosa treated with azathioprine].
Kofoed K; Kiszka-Kanowitz M; Albrectsen JM; Andersen O
Ugeskr Laeger; 2008 Apr; 170(15):1255. PubMed ID: 18433585
[TBL] [Abstract][Full Text] [Related]
30. Small bowel Epstein-Barr virus-positive lympho-epithelioma-like carcinoma in Crohn's disease.
Vanoli A; Di Sabatino A; Biancone L; Martino M; Macciomei MC; Zorzi F; Pallone F; Solcia E; Corazza GR
Histopathology; 2017 Apr; 70(5):837-839. PubMed ID: 27891660
[No Abstract] [Full Text] [Related]
31. A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab.
Fitzgerald MP; Armstrong L; Hague R; Russell RK
J Crohns Colitis; 2013 May; 7(4):314-7. PubMed ID: 22640698
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
Gibson SE; Hsi ED
Hum Pathol; 2009 May; 40(5):653-61. PubMed ID: 19144386
[TBL] [Abstract][Full Text] [Related]
33. A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.
Honkila M; Niinimäki R; Taskinen M; Kuismin O; Kettunen K; Saarela J; Turunen S; Renko M; Tapiainen T
BMC Infect Dis; 2019 May; 19(1):404. PubMed ID: 31077135
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
Magro F; Santos-Antunes J; Albuquerque A; Vilas-Boas F; Macedo GN; Nazareth N; Lopes S; Sobrinho-Simões J; Teixeira S; Dias CC; Cabral J; Sarmento A; Macedo G
Inflamm Bowel Dis; 2013 Jul; 19(8):1710-6. PubMed ID: 23574759
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous regression of colonic lymphoma following infliximab and azathioprine withdrawal in patients with Crohn's disease.
Flynn AD; Azar JM; Chiorean MV
Inflamm Bowel Dis; 2013 Apr; 19(5):E69-70. PubMed ID: 23399737
[No Abstract] [Full Text] [Related]
36. Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.
del Valle García-Sánchez M; Gómez-Camacho F; Poyato-González A; Iglesias-Flores EM; de Dios-Vega JF; Sancho-Zapatero R
Inflamm Bowel Dis; 2004 Sep; 10(5):701-2. PubMed ID: 15472541
[No Abstract] [Full Text] [Related]
37. Azathioprine induced Epstein Barr virus-positive mucocutaneous ulcer arising in perianal fistula and abscess associated with Crohn's disease.
Matnani R; Peker D
J Crohns Colitis; 2014 Dec; 8(12):1747-8. PubMed ID: 25213810
[No Abstract] [Full Text] [Related]
38. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
39. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
[No Abstract] [Full Text] [Related]
40. Epstein-Barr virus-associated lymphoproliferative disorder in Crohn disease treated with azathioprine.
Ross S; Rajwal SK; Sugarman I; Picton S; Devlin J; Davison S; McClean P
J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):229-31. PubMed ID: 20512052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
